Search Tag: clinical management
2024 31 Jan
B•R•A•H•M•S™ sFlt-1/PlGF KRYPTOR™ Test System is available through physicians and is the first FDA-cleared biomarker test to aid in the risk assessment of progression to preeclampsia with severe features, a leading cause of maternal and fetal mortality in the U.S. 1 Labcorp, a global leader of innovative and comprehensive laboratory services...Read more
2023 13 Oct
An overview of ionised serum magnesium as an important biomarker for critically ill patients and how iMg testing is utilised at Mater Intensive Care. Ionised Serum Magnesium - An Important Biomarker Magnesium is the fourth most common cation in the body and the second most abundant intracellular cation, exceeded only by potassium....Read more
2021 09 Mar
Speakers Prof. Roberta Polverosi Dr. Diana Penha Prof Paolo Spagnolo Find Affidea On Social Media Read more
2019 13 Sep
In 2007, a study funded by the National Institutes of Health assessed the use of predictive models to calculate the risk of early-onset sepsis (EOS) in neonatal patients, accounting for multiple variables. The main objectives of the study were to assess the links between the risk factors and the infection outcomes; use patient data collected from...Read more
2016 06 Dec
The International Sepsis Forum (ISF) is a non-profit organization, focused on improving the management of sepsis through educational efforts. A council of international experts and opinion leaders heads the ISF and drives all its activities. The ISF provides international consensus on the latest understanding of key scientific and clinical issues through...Read more